Published in Diabetes Care on May 01, 1998
Metabolic decompensation in pump users due to lispro insulin precipitation. BMJ (2002) 1.07
Insulin fibrillation and protein design: topological resistance of single-chain analogs to thermal degradation with application to a pump reservoir. J Diabetes Sci Technol (2012) 1.07
Quantitation of humalog insulin by reversed-phase high-performance liquid chromatography. J Diabetes Sci Technol (2007) 0.75
Stability of insulin lispro in insulin infusion systems. Diabetes Care (1997) 3.16
The Local Effect of the Injection of Gases into the Subcutaneous Tissues. Am J Pathol (1930) 5.20
Primary Multiple Hemangioma of the Spleen with Multiple Liver Metastases. Am J Pathol (1928) 5.00
Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Am J Clin Nutr (1979) 3.84
A comparison of similarity measures for use in 2-D-3-D medical image registration. IEEE Trans Med Imaging (1998) 3.30
RIEDEL'S STRUMA AND STRUMA LYMPHOMATOSA (HASHIMOTO): A COMPARATIVE STUDY. Ann Surg (1937) 3.29
Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med (1978) 2.92
Source of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Carbohydrate sources, vitamins, and minerals. Am J Clin Nutr (1983) 2.43
Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm (2001) 1.98
Studies of male survivors of myocardial infarction. XII. Relation of serum lipids and lipoproteins to survival over a 10-year period. Can Med Assoc J (1970) 1.68
Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.54
The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. Circulation (1986) 1.50
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb (1993) 1.45
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med (1978) 1.38
The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J Biol Chem (1983) 1.30
Consensus reports: implications for the management of hypercholesterolemia and for future research. CMAJ (1989) 1.29
Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Can J Cardiol (1999) 1.28
Hepatic bipolar radiofrequency ablation creates coagulation zones close to blood vessels: a finite element study. Med Biol Eng Comput (2003) 1.24
Impact of different blood lipid evaluation and treatment guidelines on the proportion of Canadians identified and treated for elevated blood cholesterol. Canadian Heart Health Surveys Research Group. Can J Cardiol (1999) 1.23
A hepatic lipase gene mutation associated with heritable lipolytic deficiency. J Clin Endocrinol Metab (1991) 1.21
Familial dementia of adult onset with pathological findings of a 'non-specific' nature. Brain (1981) 1.17
Coffee and serum-lipids in coronary heart-disease. Lancet (1966) 1.17
The Fibrous Connective Tissue of the Artificially Induced Maternal Placenta in the Rat with Particular Reference to the Relationship Between Reticulum and Collagen. Am J Pathol (1942) 1.17
Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. Proc Natl Acad Sci U S A (1997) 1.16
Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease. J Clin Invest (1987) 1.13
Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis (1990) 1.12
Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein. Proc Natl Acad Sci U S A (1987) 1.07
Leucocyte esterase determination as a secondary procedure for urine screening. J Clin Pathol (1985) 1.05
Identification of coagulase-negative Staphylococci isolated from urinary tract infections. Am J Clin Pathol (1986) 1.05
A three-component deformation model for image-guided surgery. Med Image Anal (1998) 1.04
Nature of the familial influence on plasma lipid levels. Atherosclerosis (1979) 1.04
Studies of male survivors of myocardial infarction. 8. The electrocardiogram and ten-year survival. Am J Cardiol (1966) 1.04
Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit (1993) 1.02
Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population. Can Med Assoc J (1980) 1.00
Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency. Biochem Biophys Res Commun (1991) 0.99
Serum triglyceride: method of estimation and levels in normal humans. Can Med Assoc J (1966) 0.99
Sulfated insulin in mild, moderate, severe and insulin-resistant diabetes mellitus. Diabetes (1966) 0.99
A comprehensive scoring system for evaluating Noonan syndrome. Am J Med Genet (1981) 0.99
Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clin Chem (1997) 0.99
Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin Endocrinol (Oxf) (1997) 0.96
Hyaline Degeneration of the Islands of Langerhans in Non-Diabetics. Am J Pathol (1927) 0.96
5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol (1991) 0.96
Clinical comparison of the enterotube II and API 20E systems for bacterial identification. Am J Clin Pathol (1983) 0.95
Uptake and degradation of human chylomicrons by macrophages in culture. Role of lipoprotein lipase. Arteriosclerosis (1983) 0.94
Normative standards of plasma cholesterol and triglyceride concentrations in Canadians of working age. Can Med Assoc J (1977) 0.92
Sex difference in high density lipoprotein cholesterol in six countries. Am J Epidemiol (1996) 0.91
Apolipoprotein C-II deficiency associated with nonfunctional mutant forms of apolipoprotein C-II. Can J Biochem Cell Biol (1984) 0.89
Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations. Arterioscler Thromb (1991) 0.88
Nonspecific T suppressor factor (nsTsF) cascade in contact sensitivity: nsTsF-1 causes an Ly-1+2- I-A+ immune T cell to produce a second, genetically restricted, nsTsF-2. J Immunol (1986) 0.88
The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Prevalence Study. Circulation (1980) 0.88
Scorpionism. Can Med Assoc J (1963) 0.87
Pathogenesis of acidosis in hereditary fructose intolerance. Metabolism (1979) 0.87
Directed case study method for teaching human anatomy and physiology. Am J Physiol (1996) 0.87
The pathology and pathogenesis of mammary tumors occurring spontaneously in the Albany strain of rats. Am J Pathol (1940) 0.87
Usefulness of gas chromatographic profiles of plasma total lipids in diagnosis of phytosterolemia. J Chromatogr (1986) 0.86
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis. Circulation (1984) 0.86
Blood lead values in pregnant women and their offspring. Am J Obstet Gynecol (1974) 0.86
Studies of male survivors of myocardial infarction. IX. Mortality experience and insurability. Can Med Assoc J (1967) 0.86
Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency. Atherosclerosis (1982) 0.85
Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease. Arteriosclerosis (1982) 0.84
An apolipoprotein CII mutation, CIILys19----Thr' identified in patients with hyperlipidemia. Dis Markers (1992) 0.84
Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 3. Synergistic effect of sucrose and animal fat on serum lipids. Atherosclerosis (1973) 0.83
Dietary carbohydrate and fat, serum lipoproteins, and human atherosclerosis. Am J Clin Nutr (1967) 0.83
Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management. Anesth Analg (1999) 0.82
Heart size and ten-year survival after uncomplicated myocardial infarction. Am Heart J (1969) 0.82
Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. Biochem Biophys Res Commun (1979) 0.82
Subcellular pathology of hereditary fructose intolerance. Am J Med (1968) 0.82
Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: modulatory role of testosterone via morphine clearance. J Pharmacol Exp Ther (2001) 0.81
Lipid class and molecular species interrelationships among plasma lipoproteins of normolipemic subjects. J Chromatogr (1981) 0.81
Elevated LDL triglyceride concentrations in subjects heterozygous for the hepatic lipase S267F variant. Arterioscler Thromb Vasc Biol (1998) 0.81
The inheritance of sinking-pre-beta lipoprotein and its relation to the Lp(a) antigen. Clin Genet (1982) 0.81
Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation. Bone Marrow Transplant (2000) 0.80
Studies of male survivors of myocardial infarction. VI. The electrocardiogram. Can Med Assoc J (1965) 0.80
Two-chain disulphide-bonded structure of antigen-specific T-helper factor: both chains are necessary for activity and their interaction is I-A restricted. Immunology (1985) 0.79
A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects. Diabetes (1973) 0.79
An enzyme immunoassay for 6-sulphatoxy-melatonin in human urine. J Pineal Res (1996) 0.79
Phytosterolemia and hypercholesterolemia in childhood. J Pediatr (1986) 0.79
The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group. Can J Cardiol (1999) 0.78
Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 2. Sucrose and starch with mixed saturated and polyunsaturated fats. Atherosclerosis (1973) 0.78
Treatment of severe Asian rickets with vitamin D-fortified chupatti flour. Arch Dis Child (1977) 0.78
The beta very low density lipoprotein present in hepatic lipase deficiency competitively inhibits low density lipoprotein binding to fibroblasts and stimulates fibroblast acyl-CoA:cholesterol acyltransferase. J Biol Chem (1988) 0.78
A twin study on the heritability of lipoprotein fractions. Acta Genet Med Gemellol (Roma) (1976) 0.78
The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol (1999) 0.77
Comparative determination of plasma phospholipids by automated gas--liquid chromatographic and manual colorimetric phosphorus methods. J Chromatogr (1980) 0.77
Lipid class and molecular species interrelationships among plasma lipoproteins of type III and type IV hyperlipemic subjects. J Chromatogr (1982) 0.77
Homozygous hemoglobin constant spring with normal electrophoresis. A possible cause for under-diagnosis. Ann N Y Acad Sci (1998) 0.77
Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro. Growth Regul (1996) 0.77
Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages. Arterioscler Thromb (1993) 0.77
Identification of disulfide-linked apolipoprotein species in human lipoproteins. J Lipid Res (1993) 0.76
Leguminous seeds in the dietary management of hyperlipidemia. Am J Clin Nutr (1983) 0.76
Familial hepatic lipase deficiency. Adv Exp Med Biol (1986) 0.76
Immobilization hypercalcemia. South Med J (1982) 0.76
Comparative studies of triacylglycerol structure of very low density lipoproteins and chylomicrons of normolipemic subjects and patients with type II hyperlipoproteinemia. Lipids (1985) 0.76
The effect of age on radiocephalic fistula patency. J Vasc Access (2007) 0.76
Parental hypertension and risk of diabetic nephropathy. Diabet Med (1998) 0.75
Commentaries. Can Med Assoc J (1967) 0.75
Some comments on exercise and changes in blood chemistry. Can Med Assoc J (1967) 0.75
Fetal proteins in uremia: a metabolic encore? J Lab Clin Med (1997) 0.75
Hormonal and metabolic studies in pheochromocytoma. Can Med Assoc J (1970) 0.75